Blood cancers, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 1/2
This trial looked at whether acalabrutinib is a useful treatment for people with diffuse large B cell lymphoma (DLBCL). DLBCL is a type of non-Hodgkin lymphoma.
The trial was supported by Cancer Research UK. People could join between 2017 and 2020. The team published the results in 2026.
Recruitment start: 1 May 2017
Recruitment end: 30 January 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Andrew Davies
Cancer Research UK
CRUK University of Southampton Clinical Trials Unit
Experimental Cancer Medicine Centres (ECMC)
Haematological Malignancies Diagnostic Service (HMDS)
University Hospital Southampton NHS Foundation Trust
This is Cancer Research UK trial number CRUKDE/16/006
Last reviewed: 20 Oct 2026
CRUK internal database number: 14311
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
